What Happened?
New York, NY-based Neurotrope Appointed Michael Ciraolo as Chief Operating Officer
About the Company
Neurotrope is discovering restorative therapeutics for patients with life-altering neurodegenerative diseases and development disorders. We are a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders. Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes various treatment approaches for serious and difficult-to-treat diseases such as Alzheimer`s Disease, Fragile X Syndrome and Niemann-Pick Type C
About the Person
Michael Ciraolo is Chief Operating Officer at Neurotrope. Previously, Michael held various senior IT leadership roles in the industry.
Info Source
News
Short Profile